エピソード

  • 12/20/24: Overseas pharmacies for Long COVID symptom support
    2024/12/21
    In this episode (the last of 2024!): With little support and no approved treatments, online drug markets are one way that people with Long COVID are seeking to improve their quality of life. This week, co-hosts Betsy Ladyzhets and Miles Griffis talk with producer James Salanga to recap reporting from freelancer Hannah Buttle about this phenomenon and the current state of potential Long COVID treatments. Also in this episode: the latest COVID-19 numbers, an update on H5N1, and more funding for Long COVID and myalgic encephalomyelitis (ME) research. The transcript for this podcast is ⁠available on The Sick Times' website⁠. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:02:33) COVID-19 trends (00:05:18) Top story — Overseas pharmacies for Long COVID symptom support (00:18:20) Research — More funding for NIH RECOVER-TLC and ME biomarker research (00:22:44) Outro Donate to our end-of-year fundraiser⁠⁠ and have your donation matched up to $1,000 — both one-time and monthly donations will be matched! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠⁠⁠⁠⁠Sign up here.⁠⁠⁠⁠⁠ You can also find our podcast on ⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Pocket Casts⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Amazon Music⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠iHeartRadio⁠⁠⁠⁠⁠⁠. - Mentioned in this episode (in order of appearance): Still Here: Recapping the RECOVER-TLC kickoff; Low-dose naltrexone in clinical trials; Long COVID research under Trump The Sick Times: National COVID-19 trends, December 17CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardThe Sick Times: Wastewater surveillance for Covid-19 keeps evolving. Here’s what you need to know.U.S. free COVID tests: COVID-19 Testing The Sick Times: With no approved treatments and little support, people with Long COVID turn to online drug marketsChemical & Engineering News: R&D for long COVID is collapsing World Health Organization: Substandard and falsified medical productsUniversity of Liverpool: Liverpool COVID-19 Drug Interactions The Sick Times and Long COVID Justice: Long COVID Essentials seriesLong COVID StudiesThe Sick Times: Want to enroll in a Long Covid clinical trial? This new project helps track them.The Sick Times: Research updates, December 17The Sick Times: NIH announces $147 million in additional Long COVID research funding, new budget details Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    24 分
  • 12/13/24: Rock music about living with ME/CFS in the age of COVID
    2024/12/14
    In this episode: What does it sound like to be alienated as an Jewish anti-Zionist living with ME/CFS during a mass-disabling pandemic? For Dan Fishback, it's rock music. The Sick Times' engagement editor Heather Hogan interviewed Dan about his production, which shows Saturday and Sunday at Joe's Pub at the Public Theater in New York City. Also in this episode: the latest COVID-19 numbers, and updates on two clinical trials. The transcript for this podcast is ⁠available on The Sick Times’ website⁠. You can jump to specific sections of the podcast and transcript below. (00:00:00) ⁠Intro⁠ (00:01:42) ⁠COVID-19 trends⁠ (00:05:18) ⁠Top story: A rock music production about living with ME/CFS — Dan Fishback is Alive, Unwell, and Living in his Apartment (00:22:53) ⁠Research: Evusheld 2.0 clinical trial, CoRE clinical trial testing HIV drugs⁠ (00:27:26) ⁠Outro⁠ Donate to our ⁠end-of-year fundraiser⁠ and have your donation matched up to $1,000 — both one-time and monthly donations will be matched! 

 Still Here is an abridged version of ⁠The Sick Times’ newsletter⁠, which publishes weekly on Tuesdays. You can also find our podcast on ⁠Apple Podcasts⁠,⁠ Pocket Casts⁠,⁠ Amazon Music⁠,⁠ and iHeartRadio⁠. - This episode contains a promo swap with the podcast ⁠Public Health is Dead⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, December 10CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardU.S. free COVID tests: COVID-19 Testing Dan Fishback is Alive, Unwell, and Living in His ApartmentDark Disabled StoriesSplit BritchesThe Sick Times: Research updates, December 10The Sick Times: Still Here, October 18: Links and transcript Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Dan Fishback: Marching from Home (personal demo)Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    28 分
  • 12/3/24: Long COVID research under Trump; anniversary zine
    2024/12/03
    In this episode: How could funding for and progress on Long COVID research change under the Trump administration? Co-host Betsy Ladyzhets talks with producer James Salanga about her reporting to map out the potential landscape. Also in this episode: the latest COVID-19 numbers, an anniversary zine and update about how our end-of-year fundraiser is going, a study examining SARS-CoV-2 spike protein in the skull, and more. The transcript for this podcast is available on The Sick Times’ website. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:01:31) COVID-19 trends (00:05:37) Long COVID research under Trump (00:18:48) Fundraiser update, anniversary zine (00:22:11) Research: SARS-CoV-2 spike protein in skull, valacyclovir and celecoxib clinical trial (00:24:54) Outro Donate to our end-of-year fundraiser and have your donation matched up to $1,000 — both one-time and monthly donations will be matched! 

 Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly on Tuesdays. You can also find our podcast on Apple Podcasts, Pocket Casts, Amazon Music, and iHeartRadio. - This episode contains a promo swap with the podcast Public Health is Dead. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, December 3 CDC wastewater dashboard Biobot wastewater risk reports WastewaterSCAN dashboard Susanne Rust post: H5N1 in CA U.S. free COVID tests: COVID-19 Testing Instagram: PPE for California CVS: iHealth COVID-19/Flu A&B 3-in-1 Home Rapid Test Kit, 2 CT (not sponsored, just an example of the product mentioned) The Sick Times: “Don’t give up hope”: Long COVID advocates and researchers say crucial work will continue under Trump Wall Street Journal (op-ed): The High Cost of Disparaging Natural Immunity to Covid Mother Jones: Congress Has One Month to Save a Key Medicare Benefit The Sick Times: Support Long COVID journalism in our end-of-year fundraiser The Sick Times: Special edition zine: One year of The Sick Times Cell Host & Microbe: Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19 The Sick Times: Research updates, November 26 Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece)Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    26 分
  • 11/22/24: Where are kids' Long COVID clinical trials?
    2024/11/23
    In this episode: Where are the Long COVID clinical trials for kids? There are only two pediatric clinical trials testing drugs to treat Long COVID in kids — and only one of them is in the U.S. This week, reporter Simon Spichak speaks with podcast producer James Salanga about why there are so few of these pediatric clinical trials. Also in this episode: co-hosts Miles Griffis and Betsy Ladyzhets share the latest COVID-19 numbers, disappointing results from the BC 007 clinical trial, and details about REVERSE-LC recruiting participants. The transcript for this podcast is available on The Sick Times' website. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:01:41) COVID-19 trends (00:05:45) Top story — Lack of pediatric clinical trials for Long COVID (00:18:28) Research — BC 007 trial results, REVERSE-LC recruitment (00:23:18) Outro and credits Donate to our end-of-year fundraiser⁠ and have your donation matched up to $1,000 — both one-time and monthly donations will be matched! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠⁠⁠⁠Sign up here.⁠⁠⁠⁠ You can also find our podcast on ⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Pocket Casts⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Amazon Music⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠iHeartRadio⁠⁠⁠⁠⁠. - This podcast contains a promo swap with the upcoming Public Health is Dead. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, November 19CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardCDC: Vaccination Trends | Respiratory IllnessesU.S. free COVID tests: COVID-19 Testing The Sick Times: Why are there almost no clinical trials for kids with Long COVID?The Daily Beast: Stanford Medicine Long COVID Study Blows Up Because of Unmasked Staff The Sick Times: Research updates, November 19 REVERSE-LC website Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    24 分
  • 11/15/24: One year of The Sick Times!
    2024/11/16
    This week, we celebrate one year of The Sick Times! The Sick Times team discusses the newsroom's origin story, what the publication means to them, and what the next year (and hopefully years, plural) holds. Also in this episode: the latest COVID-19 numbers, and recapping the team's coverage of the Fall 2024 PolyBio Symposium on Long COVID Research. The transcript for this podcast is ⁠available on The Sick Times' website⁠. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro⁠ ⁠(00:01:24) COVID-19 trends⁠ (00:05:14) ⁠Research — Recapping Fall 2024 PolyBio Symposium on Long COVID Research (00:09:08) Top story — One year of The Sick Times⁠ (00:28:52) Outro and credits⁠ Want to give us a birthday gift?Donate to our end-of-year fundraiser⁠ and have your donation matched! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠⁠⁠Sign up here.⁠⁠⁠ You can also find our podcast on ⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠, ⁠⁠⁠⁠Pocket Casts⁠⁠⁠⁠, ⁠⁠⁠⁠Amazon Music⁠⁠⁠⁠, and ⁠⁠⁠⁠iHeartRadio⁠⁠⁠⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, November 12CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardCDC: Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy WorkersInstagram: @ppeforcaliforniaU.S. free COVID tests: COVID-19 Testing The Sick Times: Live blog: Following the Fall 2024 Polybio Symposium on Long COVID ResearchThe Sick Times: Press release: The Sick Times announces one year of covering the Long COVID crisisThe Sick Times: ‘They bungled it:’ NIH documents reveal how $1.6 billion Long Covid initiative has failed so far to meet its goalsThe Sick Times: Q&A: NIH Director Dr. Monica BertagnolliThe Sick Times: A brief, oral history of mask blocs: Part 1The Sick Times: A brief, oral history of mask blocs: Part 2The Sick Times: A brief, oral history of mask blocs: Part 3 The Sick Times x Them: These are the drag artists and organizers fighting to make queer spaces more COVID safeThe Sick Times: Introducing Long COVID Essentials, a new resource series Public Health is DeadDeath Panel Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Party hornPixabay: Happy Birthday To You - Bossa Nova style arrangementPixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    30 分
  • 11/10/24: SICK Pride in South Africa; The Sick Times' end-of-year fundraiser
    2024/11/10
    In this episode: Disability visibility via SICK Pride in South Africa and The Sick Times' end-of-year fundraiser. Sam Pearce, a Cape Town-based writer living with myalgic encephalomyelitis (ME), and Mlindeni Gabela, the Long COVID Ambassador for ME and Long COVID Unite South Africa, share their experience organizing SICK Pride, an event creating visibility for their illnesses. Co-hosts Betsy Ladyzhets and Miles Griffis talk with podcast producer James Salanga about The Sick Times' end of year fundraiser. Also in this episode: the latest COVID-19 numbers, and an $800,000 grant for a clinical trial of a repurposed drug that could help with immune or infection-related dysfunction in Long COVID. The transcript for this podcast is ⁠available on The Sick Times' website⁠. You can jump to specific sections of the podcast and transcript below. (00:00:00) ⁠Intro⁠ (00:01:16) ⁠COVID-19 trends⁠ (00:03:58) ⁠⁠Top story — SICK Pride⁠⁠ (00:12:15) ⁠Top story — End-of-year fundraiser⁠ (00:18:12) ⁠Research — Rapamycin clinical trial (00:20:06) ⁠Outro and credits⁠ Donate to our end-of-year fundraiser and have your donation matched up to $1,000 — both one-time and monthly donations will be matched! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠⁠⁠Sign up here.⁠⁠⁠ You can also find our podcast on ⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠, ⁠⁠⁠⁠Pocket Casts⁠⁠⁠⁠, ⁠⁠⁠⁠Amazon Music⁠⁠⁠⁠, and ⁠⁠⁠⁠iHeartRadio⁠⁠⁠⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, November 5CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardU.S. free COVID tests: COVID-19 Testing The Sick Times: We set out to make our 'invisible illness' visible in South Africa with SICK PrideThe Sick Times: Support Long COVID journalism in our end-of-year fundraiserThe Sick Times: Research updates, November 5The Sick Times: Still Here, October 18The Sick Times: New Long COVID and complex disease center at Mount Sinai set to be a leader in research, clinical care Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    21 分
  • 11/1/24: Mask bloc oral histories
    2024/11/02
    Mask blocs have been a crucial pillar of mutual aid in communities around the globe, as community members undertake the work of public health organizations to keep each other safe. This week, oral histories from mask bloc organizers are interspersed with some context from journalist and author Britta Shoot, who put together a three-part series collaging said oral histories. Also in this episode: the latest COVID-19 numbers, and the National Institute of Health officially seeks input on its RECOVER-Treating Long COVID initiative. The transcript for this podcast is available on The Sick Times' website. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:01:31) COVID-19 trends (00:04:32) Research — RECOVER-TLC request for info (00:06:45) Top story — Mask bloc oral histories (00:21:19) Outro and credits Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠⁠Sign up here.⁠⁠ You can also find our podcast on ⁠⁠⁠Apple Podcasts⁠⁠⁠, ⁠⁠⁠Pocket Casts⁠⁠⁠, ⁠⁠⁠Amazon Music⁠⁠⁠, and ⁠⁠⁠iHeartRadio⁠⁠⁠. - Mentioned in this episode (in order of appearance): The Sick Times: “A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meetingThe Sick Times: National COVID-19 trends, October 29CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardNIH: Submit ideas for therapeutics and biologics via the RECOVER-TLC Intervention Information Request FormNIH: Share interest to serve on a RECOVER-TLC working groupNIH: Submit biomarkers for Long COVIDNIH: Submit general feedback on RECOVER-TLCU.S. free COVID tests: COVID-19 Testing The Sick Times: A brief, oral history of mask blocs: Part 1The Sick Times: A brief, oral history of mask blocs: Part 2The Sick Times: A brief, oral history of mask blocs: Part 3 The Sick Times: “Perfect storm” of criminalization: Analyzing mask bansThe Sick Times: Mask bans and proposed bans by state COVID Action Map Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    22 分
  • 10/25/24: Low-dose naltrexone in clinical trials
    2024/10/26
    This week, co-hosts Betsy Ladyzhets and Miles Griffis talk with podcast producer James Salanga about clinical trials looking at low-dose naltrexone (LDN) as a potential drug for people living with Long COVID and ME. Also in this episode: the latest COVID-19 numbers, and a new survey of around 70,000 people in China looking at Long COVID, reinfections, and more. The transcript for this podcast is available on The Sick Times' website. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:01:10) COVID-19 trends (00:03:22) Top story — Low-dose naltrexone clinical trials (00:17:40) Research — Long COVID facts and findings in thousands of Chinese survey participants (00:23:07) Outro and credits Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠Sign up here.⁠ You can also find our podcast on ⁠⁠Apple Podcasts⁠⁠, ⁠⁠Pocket Casts⁠⁠, ⁠⁠Amazon Music⁠⁠, and ⁠⁠iHeartRadio⁠⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 22CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardNature: Daily briefing: COVID protections eliminated a strain of flu CDC: Vaccination Trends | Respiratory IllnessesU.S. free COVID tests: COVID-19 TestingThe Sick Times: Clinical trials explore how Low-Dose Naltrexone could help people with Long COVIDThe Lancet: Regional Health — Western Pacific: Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participantsThe Lancet: Regional Health — Western Pacific: Long Covid is a significant health crisis in China too Research Square: Long COVID and associated outcomes following COVID-19 reinfections: Insights from an International Patient-Led Survey Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    24 分